Global MMR Vaccines Market Growth 2023-2029

Global MMR Vaccines Market Growth 2023-2029

The MMR vaccine (also known as the MPR vaccine after the Latin names of the diseases) is an immunization vaccine against measles, mumps, and rubella (German measles). It is a mixture of live attenuated viruses of the three diseases, administered via injection. It was first developed by Maurice Hilleman while at Merck.

LPI (LP Information)' newest research report, the “MMR Vaccines Industry Forecast” looks at past sales and reviews total world MMR Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected MMR Vaccines sales for 2023 through 2029. With MMR Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world MMR Vaccines industry.

This Insight Report provides a comprehensive analysis of the global MMR Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on MMR Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global MMR Vaccines market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for MMR Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global MMR Vaccines.

The global MMR Vaccines market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

Measles, mumps, and rubella are the three common contagious airborne diseases that are highly caused by virus transmitted by sneezing and coughing of the infected person, which could lead to serious complications or death among children. Vaccines of these diseases are sold as attenuated viral vaccines, manufactured in a lyophilised formulation, which requires reconstitution with water for injection diluent and are available in two forms i.e. monovalent as well as combinational vaccines. Combinational MMR vaccines comprises mixture of two or more viral strains. These measles, mumps, and rubella vaccines are administered by subcutaneous injection to children as well as adults.

This report presents a comprehensive overview, market shares, and growth opportunities of MMR Vaccines market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Monovalent
Combinational
Divalent
Trivalent

Segmentation by application
Pediatrics
Adolescents
Adults
Elderly

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GlaxoSmithKline
Medlmmune
Merck
Sanofi Pasteur
Serum Institute

Key Questions Addressed in this Report

What is the 10-year outlook for the global MMR Vaccines market?

What factors are driving MMR Vaccines market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do MMR Vaccines market opportunities vary by end market size?

How does MMR Vaccines break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.